Thus, while IL-6 contributes to host defense in colitis by enhancing an M1-mediated pro-inflammatory response, its sustained expression in a chronic inflammatory milieu can promote macrophage reprogramming toward an M2 phenotype, ultimately altering the local immune landscape to support tumor progression. Here, IL6 is linked to colitis.